Halitosis Treatment Market Research Report - Global Forecast till 2027

Halitosis treatment market information: by type (pathologic halitosis, others), by indication (respiratory, liver, kidney, gastrointestinal, systemic, others), by diagnostic tests (halimeter, gas chromatography, BANA Test, β-galactosidase activity assay, others), by drug treatment (antacids, antiseptics, ranitidine, others) - Global forecast till 2027

ID: MRFR/Pharma/2493-CR | August 2017 | Region: Global | 153 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Synopsis of Global Halitosis Treatment Market

Market scenario

Halitosis is a clinical condition characterized by unpleasant odor present in the mouth due to various periodontal and chronic diseases. It has become a social problem affecting large number of people across the world. The most common cause of halitosis is lack of oral hygiene and lack of awareness about diagnosis of this disease. Halitosis treatment market is expected to show a massive growth due to availability of a wide range of dental health care products, increasing geriatric population and rising prevalence of periodontal diseases. The global halitosis treatment market is expected to reach USD 22,153.4 billion by 2023, and the market is projected to grow at a healthy CAGR of 18.58% during the forecast period 2017-2023.

Research Methodology

 Research methodology halitosis treatment markets

Sources: Mayo Clinic, Healthline Media, U.S. Department of Health and Human Services MRFR Analysis

Intended Audience



  • Dental care products manufacturers & suppliers

  • Research and development (R&D) companies

  • Hospitals and clinics

  • Academic institutes and universities



Key Players in the Global Halitosis Treatment Market

Some of key players profiled in the report are Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz, LLC (U.S), Rowpar Pharmaceuticals, Inc. (U.S), Abbott (U.S), Listerine (U.S), AstraZeneca (U.S). The report for Global Halitosis treatment market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Figure 1 Global Halitosis Treatment Market by type, 2016 (% market share) Halitosis Treatment Market by type 1

Segments:

The global halitosis treatment market is segmented on the basis type of halitosis, indication, diagnostic test and drug treatment.

On the basis of type of halitosis, the markets is segmented into pathological halitosis and others. Pathological halitosis is divided into oral pathological halitosis and extra oral pathological halitosis. Other types include physiological halitosis.

On the basis of indication, the market is segmented into respiratory, liver, kidney, gastrointestinal, systemic, and others. Respiratory segment is further sub-segmented into sinusitis, tuberculosis, emphysema, pharyngitis, pneumonia, and others. Liver segment is further sub-segmented into liver failure, gall bladder diseases, and others. Kidney segment is further sub-segmented into Uremia. Gastrointestinal segment is further sub-segmented into esophageal reflux, stomach cancer, malabsorption, and pharyngitis. Systemic segment is further sub-segmented into diabetes.

On the basis of diagnostic test, the market is segmented into halimeter, gas chromatography, BANA test, β-galactosidase activity assay, and other tests.

On the basis of drug treatment, the global halitosis treatment market is segmented into antacids, antiseptic, ranitidine and other drugs. Other drugs available of the treatment of halitosis are cetylpyridinium chloride and cimetidine. 

Regional analysis:

The global halitosis treatment market is segmented into four main regions namely America, Europe, Asia Pacific and Middle East & Africa.

The Americas account for a significant market share owing to rising prevalence of gum diseases and extensive use of oral care products such as toothpastes, mouth washes, mouth sprays, etc. In 2013, in the US, USD 810 million was spent for halitosis treatment.

Europe is the second largest market in the world whose growth is attributed to an increase in awareness regarding halitosis and products available for its treatment. Furthermore, increasing demand for new oral care products influence the market growth.

Asia Pacific region is expected to grow rapidly due to rising prevalence of chronic diseases such diabetes, respiratory diseases, kidney or liver failure with the increasing population. Rising geriatric population suffering from these diseases also contribute to the market growth.

In the Middle East & Africa, the market is expected to witness a moderate growth owing to poor economic conditions, and lack of awareness about oral health.



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 22,153.4 Billion
  CAGR   2017-2023: 18.58%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type of Halitosis, Indication, Diagnostic Test and Drug Treatment
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz, LLC (U.S), Rowpar Pharmaceuticals, Inc. (U.S), Abbott (U.S), Listerine (U.S), AstraZeneca (U.S)
  Key Market Opportunities   Dental Health Care Products Manufacturer
  Key Market Drivers   Rising incidence of periodontal disease


Frequently Asked Questions (FAQ) :


Halitosis Treatment Market is projected to grow at a 18.58% CAGR between 2020-2027.

Perfusion Imaging Market predicted to touch USD 22,153.4 billion by 2023.

The Americas is expected to lead the Halitosis Treatment Market.

Rising incidence of periodontal disease is adding market growth.

Different strategies used by market players to create a dominance in the Halitosis Treatment Market include product launches, R&D, collaborations, and mergers.

1 REPORT PROLOGUE

2 MARKET INTRODUCTION

2.1 INTRODUCTION 17

2.2 SCOPE OF STUDY 17

2.3 RESEARCH OBJECTIVE 17

2.4 ASSUMPTIONS & LIMITATIONS 18

2.4.1 ASSUMPTIONS 18

2.4.2 LIMITATIONS 18

2.5 MARKET STRUCTURE 19

3 RESEARCH METHODOLOGY: HALITOSIS MARKET

3.1 RESEARCH PROCESS 20

3.2 MARKET SIZE ESTIMATION 22

3.2.1 MARKET SHARE ANALYSIS 23

3.3 FORECAST MODEL 24

4 MARKER DYNAMICS

4.1 DRIVERS 25

4.1.1 RISING PREVALENCE OF PERIODONTAL DISEASES 25

4.1.2 GERIATRIC POPULATION 25

4.1.3 AVAILABILITY OF WIDE RANGE OF PRODUCTS 25

4.1.4 INCREASING PREVALENCE OF CHRONIC DISEASES 25

4.2 RESTRAINTS 26

4.2.1 LACK OF AWARENESS ABOUT HALITOSIS AND ITS TREATMENT 26

4.2.2 ALTERNATIVE TREATMENT 26

4.3 OPPORTUNITIES 26

4.3.1 TECHNOLOGICAL ADVANCEMENT 26

4.4 MEGA TRENDS 26

4.4.1 SHIFT FROM DIAGNOSIS TO MANAGEMENT 26

4.4.2 NANO SENSOR FOR DISEASE DIAGNOSIS 27

4.5 MACROECONOMIC INDICATORS 27

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 28

5.1.1 BARGAINING POWER OF SUPPLIERS 29

5.1.2 BARGAINING POWER OF BUYERS 29

5.1.3 THREAT OF NEW ENTRANTS 29

5.1.4 THREAT OF SUBSTITUTES 29

5.1.5 INTENSITY OF RIVALRY 29

5.2 VALUE CHAIN ANALYSIS 30

5.2.1 R&D 30

5.2.2 MANUFACTURING 30

5.2.3 DISTRIBUTION & SALES 31

5.2.4 POST-SALES SERVICES 31

5.3 PRICING ANALYSIS 32

5.4 INVESTMENT OPPORTUNITY ANALYSIS 33

6 HALITOSIS TREATMENT MARKET, BY TYPE

6.1 INTRODUCTION 34

6.2 PATHOLOGIC HALITOSIS 36

6.3 OTHER HALITOSIS 37

7 HALITOSIS TREATMENT MARKET, BY INDICATION

7.1 INTRODUCTION 38

7.2 RESPIRATORY DISORDERS 39

7.3 LIVER DISORDERS 41

7.4 KIDNEY DISORDER 42

7.5 GASTROINTESTINAL DISORDERS 43

7.6 SYSTEMIC DISORDERS 44

8 HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

8.1 INTRODUCTION 45

8.2 HALIMETER 46

8.3 GAS CHROMATOGRAPHY 47

8.4 BANA TEST 48

8.5 B- GALACTOSIDASE ACTIVITY ASSAY 49

8.6 OTHER TESTS 50

9 HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

9.1 INTRODUCTION 51

9.2 ANTACIDS 53

9.3 ANTISEPTICS 54

9.4 RANITIDINE 55

9.5 OTHER TREATMENTS 56

10 GLOBAL HALITOSIS TREATMENT MARKET, BY REGION

10.1 INTRODUCTION 57

10.2 AMERICAS 58

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.2.1 U.S. 63

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.2.2 CANADA 66

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.2.3 SOUTH AMERICA 69

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.3 EUROPE 73

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.3.1 GERMANY 77

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.3.2 FRANCE 80

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.3.3 UK 83

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.3.4 ITALY 86

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.3.5 SPAIN 89

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.3.6 EASTERN EUROPE 92

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.4 ASIA PACIFIC 96

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.4.1 JAPAN 100

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.4.2 CHINA 103

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.4.3 INDIA 106

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.4.4 AUSTRALIA 109

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.4.5 REPUBLIC OF KOREA 112

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.4.6 REST OF ASIA PACIFIC 115

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.5 MIDDLE EAST & AFRICA 118

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.5.1 MIDDLE EAST 122

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

10.5.2 AFRICA 125

HALITOSIS TREATMENT MARKET, BY TYPE

HALITOSIS TREATMENT MARKET, BY INDICATION

HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST

HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION 129

11.2 COMPANY SHARE ANALYSIS 130

11.3 ABBOTT 131

11.3.1 COMPANY OVERVIEW 131

11.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW 131

11.3.3 FINANCIAL UPDATES 131

11.3.4 KEY DEVELOPMENTS 133

11.3.5 SWOT ANALYSIS 133

11.4 ALL USA PARTNERS LLC 134

11.4.1 COMPANY OVERVIEW 134

11.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW 134

11.4.3 FINANCIAL UPDATES 134

11.4.4 KEY DEVELOPMENTS 134

11.4.5 SWOT ANALYSIS 135

11.5 ASTRAZENECA 136

11.5.1 COMPANY OVERVIEW 136

11.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW 136

11.5.3 FINANCIAL OVERVIEW 136

11.5.4 KEY DEVELOPMENT 137

11.5.5 SWOT ANALYSIS 138

11.6 COLGATE-PALMOLIVE COMPANY 139

11.6.1 COMPANY OVERVIEW 139

11.6.2 PRODUCT/BUSINESS SEGMENT OVERVIEW 139

11.6.3 FINANCIAL UPDATES 139

11.6.4 KEY DEVELOPMENTS 140

11.6.5 SWOT ANALYSIS 141

11.7 DR. HAROLD KATZ, LLC 142

11.7.1 COMPANY OVERVIEW 142

11.7.2 PRODUCT/BUSINESS SEGMENT OVERVIEW 142

11.7.3 FINANCIAL UPDATES 142

11.7.4 KEY DEVELOPMENTS 142

11.7.5 SWOT ANALYSIS 143

11.8 LISTERINE (PART OF JOHNSON & JOHNSON) 144

11.8.1 COMPANY OVERVIEW 144

11.8.2 PRODUCT/BUSINESS SEGMENT OVERVIEW 144

11.8.3 FINANCIAL UPDATES 144

11.8.4 KEY DEVELOPMENTS 145

11.8.5 SWOT ANALYSIS 146

11.9 ROWPAR PHARMACEUTICALS, INC. 147

11.9.1 COMPANY OVERVIEW 147

11.9.2 PRODUCT/BUSINESS SEGMENT OVERVIEW 147

11.9.3 FINANCIAL UPDATES 147

11.9.4 KEY DEVELOPMENTS 147

11.9.5 SWOT ANALYSIS 148

12 MRFR CONCLUSION

12.1 KEY FINDINGS 149

12.1.1 FROM CEO’S VIEW POINT 149

12.1.2 UNMET NEEDS 149

12.2 KEY COMPANIES TO WATCH 149

13 APPENDIX

13.1 DISCUSSION BLUE PRINT 150

13.2 REFERENCES 152

14 List of Tables

TABLE 1 GLOBAL HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 34

TABLE 2 GLOBAL HALITOSIS TREATMENT MARKET FOR PATHOLOGIC HALITOSIS, BY REGION, 2020-2027 (USD MILLION) 36

TABLE 3 GLOBAL HALITOSIS TREATMENT MARKET FOR OTHER HALITOSIS, BY REGION, 2020-2027 (USD MILLION) 37

TABLE 4 GLOBAL HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 38

TABLE 5 GLOBAL HALITOSIS TREATMENT MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2020-2027 (USD MILLION) 40

TABLE 6 GLOBAL HALITOSIS TREATMENT MARKET FOR LIVER DISORDERS, BY REGION, 2020-2027 (USD MILLION) 41

TABLE 7 GLOBAL HALITOSIS TREATMENT MARKET FOR KIDNEY DISORDER, BY REGION, 2020-2027 (USD MILLION) 42

TABLE 8 GLOBAL HALITOSIS TREATMENT MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2020-2027 (USD MILLION) 43

TABLE 9 GLOBAL HALITOSIS TREATMENT MARKET FOR SYSTEMIC DISORDERS, BY REGION, 2020-2027 (USD MILLION) 44

TABLE 10 GLOBAL HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 45

TABLE 11 GLOBAL HALITOSIS TREATMENT MARKET FOR HALIMETER, BY REGION, 2020-2027 (USD MILLION) 47

TABLE 12 GLOBAL HALITOSIS TREATMENT MARKET FOR GAS CHROMATOGRAPHY, BY REGION, 2020-2027 (USD MILLION) 48

TABLE 13 GLOBAL HALITOSIS TREATMENT MARKET FOR BANA TEST, BY REGION, 2020-2027 (USD MILLION) 48

TABLE 14 GLOBAL HALITOSIS TREATMENT MARKET FOR B- GALACTOSIDASE ACTIVITY ASSAY, BY REGION, 2020-2027 (USD MILLION) 49

TABLE 15 GLOBAL HALITOSIS TREATMENT MARKET FOR OTHER TESTS, BY REGION, 2020-2027 (USD MILLION) 50

TABLE 16 GLOBAL HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 51

TABLE 17 GLOBAL HALITOSIS TREATMENT MARKET FOR ANTACIDS, BY REGION, 2020-2027 (USD MILLION) 53

TABLE 18 GLOBAL HALITOSIS TREATMENT MARKET FOR ANTISEPTICS, BY REGION, 2020-2027 (USD MILLION) 54

TABLE 19 GLOBAL HALITOSIS TREATMENT MARKET FOR RANITIDINE, BY REGION, 2020-2027 (USD MILLION) 55

TABLE 20 GLOBAL HALITOSIS TREATMENT MARKET FOR OTHER TREATMENT, BY REGION, 2020-2027 (USD MILLION) 56

TABLE 21 GLOBAL HALITOSIS TREATMENT MARKET, BY REGION, 2020-2027 (USD MILLION) 57

TABLE 22 AMERICAS HALITOSIS TREATMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 59

TABLE 23 AMERICAS HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 60

TABLE 24 AMERICAS HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 60

TABLE 25 AMERICAS HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 61

TABLE 26 AMERICAS HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 62

TABLE 27 U.S. HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 63

TABLE 28 U.S. HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 64

TABLE 29 U.S. HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 65

TABLE 30 U.S. HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 65

TABLE 31 CANADA HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 66

TABLE 32 CANADA HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 67

TABLE 33 CANADA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 68

TABLE 34 CANADA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 68

TABLE 35 SOUTH AMERICA HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 69

TABLE 36 SOUTH AMERICA HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 70

TABLE 37 SOUTH AMERICA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 71

TABLE 38 SOUTH AMERICA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 71

TABLE 39 EUROPE HALITOSIS TREATMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 73

TABLE 40 EUROPE HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 74

TABLE 41 EUROPE HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 75

TABLE 42 EUROPE HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 76

TABLE 43 EUROPE HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 76

TABLE 44 GERMANY HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 77

TABLE 45 GERMANY HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 78

TABLE 46 GERMANY HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 79

TABLE 47 GERMANY HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 79

TABLE 48 FRANCE HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 80

TABLE 49 FRANCE HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 81

TABLE 50 FRANCE HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 82

TABLE 51 FRANCE HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 82

TABLE 52 UK HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 83

TABLE 53 UK HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 84

TABLE 54 U.K. HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 85

TABLE 55 UK HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 85

TABLE 56 ITALY HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 86

TABLE 57 ITALY HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 87

TABLE 58 ITALY HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 88

TABLE 59 ITALY HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 88

TABLE 60 SPAIN HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 89

TABLE 61 SPAIN HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 90

TABLE 62 SPAIN HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 91

TABLE 63 SPAIN HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 91

TABLE 64 EASTERN EUROPE HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 92

TABLE 65 EASTERN EUROPE HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 93

TABLE 66 EASTERN EUROPE HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 94

TABLE 67 EASTERN EUROPE HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 94

TABLE 68 ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 96

TABLE 69 ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 97

TABLE 70 ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 98

TABLE 71 ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 99

TABLE 72 ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 99

TABLE 73 JAPAN HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 100

TABLE 74 JAPAN HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 101

TABLE 75 JAPAN HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 102

TABLE 76 JAPAN HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 102

TABLE 77 CHINA HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 103

TABLE 78 CHINA HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 104

TABLE 79 CHINA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 105

TABLE 80 CHINA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 105

TABLE 81 INDIA HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 106

TABLE 82 INDIA HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 107

TABLE 83 INDIA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 108

TABLE 84 INDIA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 108

TABLE 85 AUSTRALIA HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 109

TABLE 86 AUSTRALIA HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 110

TABLE 87 AUSTRALIA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 111

TABLE 88 AUSTRALIA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 111

TABLE 89 REPUBLIC OF KOREA HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 112

TABLE 90 REPUBLIC OF KOREA HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 113

TABLE 91 REPUBLIC OF KOREA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 114

TABLE 92 REPUBLIC OF KOREA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 114

TABLE 93 REST OF ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 115

TABLE 94 REST OF ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 116

TABLE 95 REST OF ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 117

TABLE 96 REST OF ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 117

TABLE 97 MIDDLE EAST & AFRICA HALITOSIS TREATMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 118

TABLE 98 MIDDLE EAST & AFRICA HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 119

TABLE 99 MIDDLE EAST & AFRICA HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 120

TABLE 100 MIDDLE EAST & AFRICA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 121

TABLE 101 MIDDLE EAST & AFRICA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 121

TABLE 102 MIDDLE EAST HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 122

TABLE 103 MIDDLE EAST HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 123

TABLE 104 MIDDLE EAST HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 124

TABLE 105 MIDDLE EAST HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 124

TABLE 106 AFRICA HALITOSIS TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION) 125

TABLE 107 AFRICA HALITOSIS TREATMENT MARKET, BY INDICATION, 2020-2027 (USD MILLION) 126

TABLE 108 AFRICA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020-2027 (USD MILLION) 127

TABLE 109 AFRICA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 127

TABLE 110 ABBOTT: KEY DEVELOPMENTS 133

TABLE 111 ROWPAR PHARMACEUTICALS, INC.: KEY DEVELOPMENTS 147

15 List of Figures

FIGURE 1 GLOBAL HALITOSIS MARKET, BY TYPE, 2020 (%) 13

FIGURE 2 GLOBAL HALITOSIS MARKET, BY INDICATION, 2020 (%) 13

FIGURE 3 GLOBAL HALITOSIS MARKET, BY DIAGNOSTIC TEST, 2020 (%) 14

FIGURE 4 GLOBAL HALITOSIS MARKET, BY TREATMENT, 2020 (%) 15

FIGURE 5 GLOBAL HALITOSIS MARKET, BY REGION, 2020 (%) 16

FIGURE 6 GLOBAL HALITOSIS MARKET: MARKET STRUCTURE 19

FIGURE 7 RESEARCH PROCESS 20

FIGURE 8 MARKET ASSESMENT: TRAIGULATION APPROACH 21

FIGURE 9 GLOBAL HALITOSIS MARKET: FORECAST MODEL 24

FIGURE 10 PORTERS FIVE FORCES MODEL 28

FIGURE 11 VALUE CHAIN: HALITOSIS 30

FIGURE 12 GLOBAL HALITOSIS TREATMENT MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 35

FIGURE 13 GLOBAL HALITOSIS TREATMENT MARKET, BY INDICATION, 2020 & 2027 (USD MILLION) 39

FIGURE 14 GLOBAL HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2020 & 2027 (USD MILLION) 46

FIGURE 15 GLOBAL HALITOSIS TREATMENT MARKET, BY TREATMENT, 2020 & 2027 (USD MILLION) 52

FIGURE 16 GLOBAL HALITOSIS TREATMENT MARKET, BY REGION, 2020 & 2027 (USD MILLION) 58

FIGURE 17 AMERICAS HALITOSIS TREATMENT MARKET, BY COUNTRY, 2020 (%) 59

FIGURE 18 EUROPE HALITOSIS TREATMENT MARKET, BY COUNTRY, 2020 (%) 74

FIGURE 19 ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY COUNTRY, 2020 (%) 97

FIGURE 20 MIDDLE EAST & AFRICA HALITOSIS TREATMENT MARKET, BY COUNTRY, 2020 (%) 118

FIGURE 21 GLOBAL HALITOSIS MARKET: COMPETITIVE LANDSCAPE 129

FIGURE 22 GLOBAL HALITOSIS MARKET: COMPANY SHARE ANALYSIS 130

FIGURE 23 ABBOTT: RECENT FINANCIALS (USD MILLION) 131

FIGURE 24 ABBOTT: GEOGRAPHICAL REVENUE, 2020 (%) 132

FIGURE 25 ABBOTT: SEGMENTAL REVENUE, 2020 (%) 132

FIGURE 26 ABBOTT: SWOT ANALYSIS 133

FIGURE 27 ALL USA PARTNERS LLC: SWOT ANALYSIS 135

FIGURE 28 ASTRAZENECA: RECENT FINANCIAL 136

FIGURE 29 ASTRAZENECA: OPERATING SEGMENTS 137

FIGURE 30 ASTRAZENECA: GEOGRAPHICAL MIX 137

FIGURE 31 ASTRAZENECA: SWOT ANALYSIS 138

FIGURE 32 COLGATE-PALMOLIVE COMPANY: RECENT FINANCIALS (USD MILLION) 139

FIGURE 33 COLGATE-PALMOLIVE COMPANY: GEOGRAPHICAL REVENUE, 2020 (%) 140

FIGURE 34 COLGATE-PALMOLIVE COMPANY: SEGMENTAL REVENUE, 2020 (%) 140

FIGURE 35 COLGATE-PALMOLIVE COMPANY: SWOT ANALYSIS 141

FIGURE 36 DR. HAROLD KATZ, LLC: SWOT ANALYSIS 143

FIGURE 37 LISTERINE: RECENT FINANCIALS (USD MILLION) 144

FIGURE 38 LISTERINE: GEOGRAPHICAL REVENUE, 2020 (%) 145

FIGURE 39 LISTERINE: SEGMENTAL REVENUE, 2020 (%) 145

FIGURE 40 LISTERINE: SWOT ANALYSIS 146

FIGURE 41 ROWPAR PHARMACEUTICALS, INC.: SWOT ANALYSIS 148